Clinical Trial Update: Urgent (<24 Hours) Versus Early (24 to 48 Hours) ERCP for Patients With Mild and Moderate Acute Cholangitis [NA]

View source ↗

Summary

The trial compared urgent (<24 hours) versus early (24 to 48 hours) ERCP for patients with mild to moderate acute cholangitis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangitis

Snippet

Sponsor: Asian Institute of Gastroenterology, India | Conditions: Acute Cholangitis | NA | Status: COMPLETED